ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,507, issued on Oct. 14, was assigned to CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Paris), UNIVERSITE DE MONTPELIER (Montpelier, France) and CENTER OF MOLECULAR AND MACROMOLECULAR STUDIES (Lodz, Poland).
"Sting inhibitors and their therapeutic uses" was invented by Nadine Laguette (Clapiers, France), Jessica Guerra (Montpellier, France), Barbara Nawrot (Dabrowka Wielka, Poland) and Renata Kaczmarek (Lodz, Poland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds of formula (I), their diastereoisomers and their salts, for use for inhibiting cancer-related inflammation, notably via STING interaction."
The pat...